Globus Medical Stock Zacks

The company not only has a favorable growth score, but also carries a top zacks rank. Globus medical inc has approached nuvasive inc, a u.s.

Analysts Estimate Globus Medical Gmed To Report A Decline In Earnings What To Look Out For - October 28 2021 - Zackscom

Gmed investment & stock information.

Globus medical stock zacks. For globus medical, the most accurate estimate is lower than the zacks consensus estimate, suggesting that analysts have recently become. Globus medical (gmed) is one such stock that our proprietary system currently recommends. Get the latest globus medical, inc.

The medical device company reported $0.50 earnings per share (eps) for the quarter, beating the zacks' consensus estimate of $0.45 by $0.05. (nyse:gmed) will announce sales of $229.77 million for the current fiscal quarter, zacks reports. Globus medical has gained 27.3% since the start of the year compared to the.

Globus medical's stock was trading at $38.05 on march 11th, 2020 when coronavirus reached pandemic status according to the world health organization (who). Manufacturer of equipment for minimally invasive spine surgery with a market value of $3 billion, with an acquisition offer, people familiar with the matter said. Since then, gmed shares have increased by 65.7% and is now trading at $63.05.

Over the past 90 days, the zacks consensus estimate for globus medical’s 2021 earnings has moved 1% north to $2.01. Globus medical (nyse:gmed) last issued its quarterly earnings results on thursday, november 4th. Nuvasive currently has a zacks rank #5 (strong sell) while globus medical carries a zacks rank #3 (hold).

You can see the complete list of today’s zacks #1 rank (strong buy) stocks here. Globus medical has a 12 month low of $58.87 and a 12 month high of $84.23. This compares to earnings of.

View which stocks have been most impacted by. Globus medical (gmed) delivered earnings and revenue surprises of 24.44% and 10.60%, respectively, for the quarter ended june 2021. Analysts forecast that globus medical, inc.

Globus medical (gmed) came out with quarterly earnings of $0.50 per share, beating the zacks consensus estimate of $0.45 per share. Shares of globus medical (gmed) have been strong performers lately, with the stock up 7.2% over the past month. Five analysts have issued estimates for globus medical's earnings, with the highest sales estimate coming in at $230.50 million and the lowest estimate coming in at $228.04 million.

Do the numbers hold clues to what lies ahead for the stock? The potential combination would accelerate consolidation in the spine surgery market, where smaller players are turning to.

Heres Why You Should Hold On To Globus Medical Gmed For Now